| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 1038 |
| 1 | LETROZOLE | 939 |
| 2 | BEVACIZUMAB | 846 |
| 3 | FULVESTRANT | 790 |
| 4 | RIBOCICLIB | 749 |
| 5 | PACLITAXEL | 745 |
| 6 | EVEROLIMUS | 696 |
| 7 | LETROZOLE TABLETS | 682 |
| 8 | TRASTUZUMAB | 673 |
| 9 | DOCETAXEL | 622 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REGORAFENIB | 330 | 0.0284 |
| 1 | INTERLEUKIN-10 | 10 | 0.0279 |
| 2 | VINORELBINE | 183 | 0.0263 |
| 3 | FULVESTRANT | 790 | 0.0236 |
| 4 | RIBOCICLIB | 749 | 0.0229 |
| 5 | EXEMESTANE | 413 | 0.0192 |
| 6 | ADO-TRASTUZUMAB EMTANSINE | 162 | 0.0192 |
| 7 | SORAFENIB | 395 | 0.0191 |
| 8 | EVEROLIMUS TABLETS | 309 | 0.0181 |
| 9 | ANASTROZOLE TABLETS | 360 | 0.0164 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 2147 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 1531 |
| 2 | Aromatase Inhibitor [EPC] | 1510 |
| 3 | Platinum-based Drug [EPC] | 1352 |
| 4 | Microtubule Inhibitor [EPC] | 1212 |
| 5 | Corticosteroid [EPC] | 946 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 882 |
| 7 | Estrogen Receptor Antagonist [EPC] | 805 |
| 8 | mTOR Inhibitor Immunosuppressant [EPC] | 735 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 730 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 805 | 0.0199 |
| 1 | Aromatase Inhibitor [EPC] | 1510 | 0.0133 |
| 2 | Actinomycin [EPC] | 26 | 0.0118 |
| 3 | Lymphocyte Growth Factor [EPC] | 13 | 0.0103 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 703 | 0.0094 |
| 5 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 6 | Provitamin D2 Compound [EPC] | 256 | 0.0086 |
| 7 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 8 | 0.0074 |
| 8 | Microtubule Inhibitor [EPC] | 1212 | 0.0073 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 336 | 0.0071 |